medigraphic.com
SPANISH

Revista Mexicana de Anestesiología

ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number S1

<< Back Next >>

Rev Mex Anest 2011; 34 (S1)

Perioperative management of ventricular assist device patients undergoing non-cardiac surgery

Grigore A
Full text How to cite this article

Language: English
References: 9
Page: 288-292
PDF size: 673.91 Kb.


Key words:

No keywords

Text Extraction

Congestive heart failure (CHF) is a pathophysiologic state of inadequate myocardial contraction and/or relaxation leading to decreased cardiac output and inadequate organ perfusion. CHF, a leading cause of morbidity and mortality, can result from a variety of insults to the myocardial tissue. According to American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the evaluation and management of chronic heart failure there are four classes based on stages of the syndrome (Table I).


REFERENCES

  1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 2001;104:2996-3007.

  2. Francis GS, Goldsmith SR, Levine TB, et al. The neurohumoral axis in congestive heart failure. Ann Int Med 1984;101:370-377.

  3. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med 1990;323:236-241.

  4. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004;23:796-803.

  5. Miller LW, Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant 2006;25:756-64.

  6. Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62:675–681.

  7. Grigore A, Poindexter B, Vaughn WK, Nussmeier N, Frazier OH, Cooper JR, Gregoric I, Buja LM, Bick R. Alterations in Alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device. Journal of Heart and Lung Transplantation 2005;24:609-613.

  8. Santamore WP, Gray LA. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg 1996;61:350-6.

  9. Pavie A, Leger P. Physiology of univentricular versus biventricular support. Ann Thorac Surg 1996;61:347-49.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Anest. 2011;34